|
|
Article: U.S. Genomics Scores $7.5M Federal Biodefense Contract.
- Article from:
- BIOWORLD Today
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Staff Writer
Working with the U.S. Department of Homeland Security, U.S. Genomics Inc. received a $7.5 million Phase I contract to develop a biological sensor for biodefense applications.
During the 18-month contract, U.S. Genomics will tailor its DNA-mapping technology - called GeneEngine - to detect and identify airborne pathogens, such as anthrax and smallpox.
"It's a great validation of our technology and a significant win for us," said Stephen DeFalco, chairman and CEO of U.S. Genomics. "We intend to provide a great solution for the government that will help make us all safer."
The Woburn, Mass.-based company's technology uses a ...